TESAMORELIN 10MG

RESEARCH PEPTIDE

TESAMORELIN

GHRH ANALOG & VISCERAL ADIPOSE RESEARCH COMPOUND

TESAMORELIN IS A SYNTHETIC ANALOG OF GROWTH HORMONE-RELEASING HORMONE (GHRH) CONSISTING OF THE FULL 44 AMINO ACID SEQUENCE OF ENDOGENOUS GHRH WITH A TRANS-3-HEXENOIC ACID MODIFICATION FOR IMPROVED STABILITY. IT HAS BEEN STUDIED IN PRECLINICAL AND CLINICAL MODELS FOR ITS ROLE IN STIMULATING ENDOGENOUS GROWTH HORMONE SECRETION AND ITS DOWNSTREAM EFFECTS ON INSULIN-LIKE GROWTH FACTOR-1 (IGF-1) LEVELS. RESEARCHERS HAVE INVESTIGATED ITS INFLUENCE ON BODY COMPOSITION, ADIPOSE TISSUE DISTRIBUTION, AND METABOLIC PARAMETERS.

PUBLISHED LITERATURE HAS EXAMINED TESAMORELIN IN THE CONTEXT OF VISCERAL FAT BIOLOGY, LIPODYSTROPHY MODELS, AND GROWTH HORMONE AXIS RESEARCH. ITS SELECTIVE GHRH RECEPTOR ACTIVITY HAS MADE IT A VALUABLE COMPOUND FOR SCIENTISTS STUDYING PITUITARY-HYPOTHALAMIC SIGNALING AND THE RELATIONSHIP BETWEEN SOMATOTROPIC AXIS ACTIVITY AND METABOLIC OUTCOMES. IT REMAINS AMONG THE MOST CLINICALLY STUDIED GHRH ANALOGS IN TRANSLATIONAL RESEARCH LITERATURE.

⚠ LEGAL DISCLAIMER — FOR RESEARCH USE ONLY

THIS PRODUCT IS INTENDED STRICTLY FOR RESEARCH PURPOSES ONLY. IT IS NOT INTENDED FOR HUMAN CONSUMPTION, VETERINARY USE, OR ANY OTHER USE. THIS PRODUCT HAS NOT BEEN EVALUATED BY THE FOOD AND DRUG ADMINISTRATION (FDA). IT IS NOT INTENDED TO DIAGNOSE, TREAT, CURE, OR PREVENT ANY DISEASE OR MEDICAL CONDITION. FOR USE BY LICENSED RESEARCH PROFESSIONALS ONLY.